Transcriptional Regulation of the Melanoma Prognostic Marker Melastatin (TRPM1) by MITF in Melanocytes and Melanoma

Cancer Research - United States
doi 10.1158/0008-5472.can-03-2440
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Putative Role of HIF Transcriptional Activity in Melanocytes and Melanoma Biology

Dermato-Endocrinology
DermatologyEndocrinologyMetabolismDiabetes
2013English

Developmental Pathways Activated in Melanocytes and Melanoma

Archives of Biochemistry and Biophysics
BiochemistryMolecular BiologyBiophysics
2014English

Pro-Survival Role of MITF in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Expression of SCF Splice Variants in Human Melanocytes and Melanoma Cell Lines: Potential Prognostic Implications

British Journal of Cancer
Cancer ResearchOncology
2000English

Molecular Biology of Normal Melanocytes and Melanoma Cells

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2013English

Antimicrobial Peptide LL-37 Participates in the Transcriptional Regulation of Melanoma Cells

Journal of Cancer
Oncology
2016English

MITF Upregulation Sensitizes Melanoma Cells to Antifolate Treatment

Cancer Discovery
Oncology
2013English

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Functional Role of MIA in Melanocytes and Early Development of Melanoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy